« Development of a flow cytometry-based method to detect neutralising antibodies in SARS-CoV-2 infection  ». 2023. One Health & Risk Management , avril, 41. https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/440.